Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse.

PloS one - 1 Jan 2014

Edmonds Mick D, Eischen Christine M

Abstract excerpt

Relapse of adenocarcinoma, the most common non-small cell lung cancer (NSCLC), is a major clinical challenge to improving survival. To gain insight into the early molecular events that contribute to lung adenocarcinoma relapse, and taking into consideration potential cell type specificity, we used stringent criteria for sample selection. We measured miRNA expression only from flash frozen stage I lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to MicroRNAs

Share to Neoplasm Staging

Share to Recurrence

Source

Open in PubMed Open full text

Identifiers

PMID: 25028925
DOI: 10.1371/journal.pone.0101802
PMCID: PMC4100742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse.PMID 25028925Read ↗

Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent DiseaseSemantic proximity Read ↗

Genetic and immunologic features of recurrent stage I lung adenocarcinoma.Semantic proximity Read ↗

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancerSemantic proximity Read ↗

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem CellsSemantic proximity Read ↗

Genomic profiling implicates candidate genes and mutagenic pathways driving lung cancer recurrenceSemantic proximity Read ↗

Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer.Semantic proximity Read ↗

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancerSemantic proximity Read ↗

Detection of oncogenic mutations in resected bronchial margins by next-generation sequencing indicates early relapse in stage IA lung adenocarcinoma patients.Semantic proximity Read ↗

Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers.Semantic proximity Read ↗

Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Target Therapy in Lung Adenocarcinoma Cell LinesSemantic proximity Read ↗

DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.